itraconazole has been researched along with Leishmaniasis, Diffuse Cutaneous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rao, M; Singh, S; Verma, A | 1 |
| de Macedo-Silva, ST; de Souza, W; Rodrigues, JC; Urbina, JA; Visbal, G | 1 |
| Bunnag, T; Chaowalit, P; Kootiratrakarn, T; Puangpet, P; Supsrisunjai, C; Wessagowit, V | 1 |
3 other study(ies) available for itraconazole and Leishmaniasis, Diffuse Cutaneous
| Article | Year |
|---|---|
Image Gallery: Mutilating diffuse cutaneous leishmaniasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Biopsy; Drug Therapy, Combination; Facial Dermatoses; Female; Humans; Itraconazole; Leishmaniasis, Diffuse Cutaneous; Skin; Treatment Outcome | 2019 |
Potent In Vitro Antiproliferative Synergism of Combinations of Ergosterol Biosynthesis Inhibitors against Leishmania amazonensis.
Topics: 14-alpha Demethylase Inhibitors; Animals; Culture Media; Drug Synergism; Drug Therapy, Combination; Ergosterol; Farnesyl-Diphosphate Farnesyltransferase; Humans; Itraconazole; Leishmania mexicana; Leishmaniasis, Diffuse Cutaneous; Lipid Droplets; Membrane Potential, Mitochondrial; Mice; Mitochondria; Parasitic Sensitivity Tests; Pyridines; Quinuclidines; Reactive Oxygen Species; Sterol 14-Demethylase; Triazoles; Trypanocidal Agents | 2015 |
Disseminated Autochthonous Dermal Leishmaniasis Caused by
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Antiviral Agents; Coinfection; Dermis; DNA, Ribosomal Spacer; Female; HIV; HIV Infections; Humans; Itraconazole; Leishmania; Leishmaniasis, Diffuse Cutaneous; Protozoan Proteins; RNA Polymerase II; Sequence Analysis, DNA; Thailand | 2017 |